(Q37768230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

0 references

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Christoph Ebenbichler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

H Tilg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Practice

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

968-983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02327.X

10.1111/J.1742-1241.2009.02327.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584230%20AND%20SRC:MED&resulttype=core&format=json

release_s3yp5s3o2ja5ddfhbx3yaltp6u

6 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s3yp5s3o2ja5ddfhbx3yaltp6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference